Ku ya 16-17 Kamena 2023, MedGence yitabiriye Inama ku Iterambere Ryiza Ry’inganda zita ku Buzima & Inama ya 8 y’Ubushinwa Pharmaceutical R&D Innovation, yabereye i Chongqing.
MedGence yahawe igihembo nka kimwe mu "2023 Top 20 R&D CRO Enterprises mu Bushinwa"!
Mbere na mbere, kuri ceromony yatangije, urutonde rwa "2022 Ubushinwa Pharmaceutical R&D Strength Ranking" rwashyizwe ahagaragara kandi MedGence yahawe igihembo nkimwe mu "2023 Top 20 Pharmaceutical CRO Enterprises mu Bushinwa"!
"2023 Pharmaceutical CRO Enterprises mu Bushinwa" yatoranijwe na komite ishinzwe gusuzuma impuguke za CRO Ranking hashingiwe ku bipimo 10 n'ibipimo byinshi, nk'amafaranga yinjira mu mwaka (amafaranga yinjira mu bikorwa), ubwiyongere bw'umwaka (%), inyungu zunguka, inyungu zunguka (%), ishoramari R&D, ubwiyongere bw'ishoramari R&D, iterambere ry’imishinga iciriritse, “2023 Imishinga 20 ya mbere y’imiti CRO mu Bushinwa”, yerekanye ubushobozi n'imbaraga.
Hagati aho, nk'umuyobozi wa TCM CXO, Dr. Yi Yueneng, Umuyobozi & Umuyobozi mukuru wa MedGence, yatumiwe mu nama ya munani y’Ubushinwa Pharmaceutical R&D Innovation maze atanga ijambo kuri “Guhera ku mperuka - Ingamba zo guteza imbere Ubuvuzi bushya bw’Ubushinwa”. Yagaragaje ko kuri ubu, igishushanyo mbonera cyo mu rwego rwo hejuru cy’iterambere ry’ubuvuzi bw’Ubushinwa cyihutishijwe kandi gitezimbere, ibidukikije bya politiki byakomeje kunozwa kandi inkunga ikiyongera, kandi ubuvuzi bw’Abashinwa bwatangiye mu bihe bya zahabu. Yagaragaje kandi ibidukikije bya politiki, ubushakashatsi n’iterambere, ndetse n’imiterere y’iterambere ry’inganda gakondo z’ubuvuzi gakondo mu Bushinwa mu bihe bishya, agaragaza umubano w’imbere mu gihugu, asesengura ibibazo by’ingutu bikiriho mu iterambere ry’ubu ry’inganda gakondo z’ubuvuzi bw’Abashinwa, anasaba ingamba zafatwa.
Hanyuma, Dr. Yi Yueneng, nkuwakiriye ihuriro ry’ibiganiro byiswe “Ese Isoko ry’Ubuvuzi bw’Ubushinwa Ibicuruzwa bishya R&D biraza”, bafatanije kuganira ku mbogamizi n’imbogamizi za R&D no guhanga udushya mu buvuzi bw’Abashinwa hamwe n’abakora inganda. Nkumufatanyabikorwa mukuru, MedGence yamye yashinze imizi munganda zimiti, akora ubushakashatsi, guhora udushya, guteza imbere inganda, no gukomeza gukorera ibigo bikorerwamo ibya farumasi mubushinwa.
Iyi nama yahuje abayobozi benshi mu bijyanye n’imicungire y’imiti, amashuri makuru na kaminuza, ibigo by’ubushakashatsi, amasosiyete y’imiti, ishami rya R & D hamwe n’abandi ntore benshi kugira uruhare muri raporo zishingiye ku bushakashatsi bwakozwe na R & D y’ubuvuzi gakondo bw’Abashinwa, guhanga udushya, amabwiriza na politiki, ubuziranenge n’umutekano, kunoza imikorere, ibikoresho bishya, ikoranabuhanga rishya n’ibindi bishyushye, kandi muri iyo nama, EnOptimus Pharmaceuticals, nk’abagize uruhare runini mu bucuruzi, EnOptimus Pharmaceuticals. mu nganda gusura! Muri iyo nama, nk’umwe mu batumiwe mu imurikagurisha, Enable Pharma yari ifite icyumba cyihariye, cyashishikarije benshi mu bakorana n’inganda gusura akazu kugira ngo bagire inama, itumanaho rya hafi n’amasosiyete akomeye y’imiti, ndetse n’ibisabwa kugira ngo hakorwe ubushakashatsi n’ibiyobyabwenge.
Igihe cyo kohereza: Nyakanga-15-2023